| |
Extrapolating Expected Efficacy, Safety, and Pharmacokinetics of Dolutegravir/Lamivudine in Pregnant People Living With HIV-1 From Pregnancy Data With Combination Dolutegravir and/or Lamivudine Antiretroviral Therapies
|
| |
| |
European Meeting on HIV & Hepatitis; May 22-24, 2024; Barcelona, Spain
William R. Short,1 Parul Patel,2 Gustavo Verdier,3 Ana Puga,2 Andrew Weber,4 Leigh Ragone,2 Eva Fernvik,4 Vani Vannappagari,2 V. Paul DiMondi,2 Bryn Jones4
1Department of Medicine, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 2ViiV Healthcare, Durham, NC, USA; 3ViiV Healthcare, Montréal, Canada;
4ViiV Healthcare, Brentford, UK
Presenting author: Parul Patel; parul.x.patel"at"viivhealthcare.com
|
|
| |
| |
|
|
|
